LY4065967 Clinical Trials (2026): 3 Studies for Healthy & Diabetic Peripheral Neuropathic Pain
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 LY4065967 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Healthy & Diabetic Peripheral Neuropathic Pain) and 225 total planned enrollment. 1 LY4065967 clinical trial is actively recruiting at 36 U.S. sites across 18 states. Most recent activity: NCT07285018 (Jul 2027).
Where to Participate: All LY4065967 Trial Sites in the U.S. (36 sites across 18 states)
Every actively recruiting LY4065967trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | Central Research Associates | Birmingham35205 | NCT07285018 | Map |
| AZ | Arizona Research Center | Phoenix85053 | NCT07285018 | Map |
| AZ | Synexus Clinical Research US, Inc. | Phoenix85020 | NCT07285018 | Map |
| CA | Desert Oasis Healthcare Medical Group | Palm Springs92262 | NCT07285018 | Map |
| CA | Artemis Institute for Clinical Research | Riverside92503 | NCT07285018 | Map |
| CA | Artemis Institute for Clinical Research | San Diego92123 | NCT07285018 | Map |
| CT | CMR of Greater New Haven | Hamden06517 | NCT07285018 | Map |
| FL | Bradenton Research Center, Inc. | Bradenton34205 | NCT07285018 | Map |
| FL | Accel Research Sites - DeLand Clinical Research Unit | DeLand32720 | NCT07285018 | Map |
| FL | K2 MEDICAL Research THE VILLAGES | Lady Lake32159 | NCT07285018 | Map |
| FL | K2 Medical Research ORLANDO | Maitland32751 | NCT07285018 | Map |
| FL | Merritt Island Medical Research, LLC | Merritt Island32952 | NCT07285018 | Map |
| FL | New Horizon Research Center | Miami33165 | NCT07285018 | Map |
| FL | Suncoast Research Group | Miami33135 | NCT07285018 | Map |
| FL | Suncoast Clinical Research, Inc. | New Port Richey34652 | NCT07285018 | Map |
| FL | Renstar Medical Research | Ocala34470 | NCT07285018 | Map |
| FL | Precision Clinical Research | Sunrise33351 | NCT07285018 | Map |
| FL | Charter Research - Lady Lake | The Villages32162 | NCT07285018 | Map |
| FL | Conquest Research | Winter Park32789 | NCT07285018 | Map |
| GA | North Georgia Clinical Research | Woodstock30189 | NCT07285018 | Map |
| IL | Northwestern University | Chicago60611 | NCT07285018 | Map |
| LA | DelRicht Research | New Orleans70115 | NCT07285018 | Map |
| MA | Lucida Clinical Trials | New Bedford02740 | NCT07285018 | Map |
| MA | MedVadis Research Corporation | Waltham02451 | NCT07285018 | Map |
| MI | Great Lakes Research Group, Inc. | Bay City48706 | NCT07285018 | Map |
| MO | StudyMetrix Research | City of Saint Peters63303 | NCT07285018 | Map |
| MO | Clinvest Research LLC | Springfield65807 | NCT07285018 | Map |
| NY | Rochester Clinical Research, LLC | Rochester14609 | NCT07285018 | Map |
| ND | Lillestol Research | Fargo58104 | NCT07285018 | Map |
| OH | META Medical Research Institute | Dayton45432 | NCT07285018 | Map |
| OK | DelRicht Research | Tulsa74133 | NCT07285018 | Map |
| PA | Altoona Center For Clinical Research | Duncansville16635 | NCT07285018 | Map |
| TX | FutureSearch Trials of Neurology | Austin78731 | NCT07285018 | Map |
| TX | Re:Cognition Health - Fort Worth | Fort Worth76104 | NCT07285018 | Map |
| WA | Northwest Clinical Research Center | Bellevue98007 | NCT07285018 | Map |
| WA | Rainier Clinical Research Center | Renton98057 | NCT07285018 | Map |
LY4065967 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | Total |
|---|---|---|---|
| P1 | 2 | 2 | |
| P2 | 1 | 1 |
Recruiting LY4065967 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07285018 | NP07A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain | P2 | Diabetic Peripheral Neuropathic Pain | 150 | Feb 2026 |
LY4065967 clinical trials by indication
Healthy (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07039045 | — | P1 | completed | A Study of [14C]-LY4065967 in Healthy Participants |
| NCT06594159 | — | P1 | completed | A Study of LY4065967 in Healthy Japanese Participants |
Diabetic Peripheral Neuropathic Pain (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07285018 | NP07 | P2 | recruiting | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain |
LY4065967 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| NP07 | NCT07285018 | P2 | recruiting | Diabetic Peripheral Neuropathic Pain | 150 | — |
All LY4065967 trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07285018 | NP07 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain | P2 | recruiting | 150 | Eli Lilly and Company | Feb 2026 |
| NCT07039045 | A Study of [14C]-LY4065967 in Healthy Participants | P1 | completed | 16 | Eli Lilly and Company | Jun 2025 | |
| NCT06594159 | A Study of LY4065967 in Healthy Japanese Participants | P1 | completed | 59 | Eli Lilly and Company | Oct 2024 |
LY4065967 clinical trials: frequently asked questions
- How many LY4065967 clinical trials are there?
- 3 LY4065967 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 2 are marked completed.
- Are LY4065967 clinical trials recruiting in 2026?
- Yes — 1 LY4065967 trial is actively recruiting in 2026, with 36 U.S. sites across 18 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4065967 being studied for?
- LY4065967 is being studied for Healthy, Diabetic Peripheral Neuropathic Pain. The trials are grouped by indication on this page.
- What phase is LY4065967 in?
- LY4065967 clinical trials span 1 Phase 2, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4065967 clinical trials?
- The lead sponsor across the most LY4065967 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4065967as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: